新南威尔士州大麻药物咨询服务事后调查分析,以告知临床指导资源开发
Myfanwy Graham1,2, Edward Eden1, Kelsey Maddison2
1Australian Centre for Cannabinoid Clinical and Research Excellence, Newcastle, New South Wales, Australia.
Neuropsychopharmacology reports
|November 17, 2024
概括
大麻药物咨询服务 (CMAS) 提供了关于医用大麻处方的真实数据. 一般医生寻求信息主要是慢性疼痛,焦虑和失眠,经常考虑CBD产品.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 公共卫生 公共卫生
背景情况:
- 新南威尔士州政府从2018年1月到2022年6月为全州大麻药物咨询服务 (CMAS) 提供资金.
- CMAS提供了基于证据的信息,以支持医疗保健专业人员处方医用大麻.
- 本研究分析了CMAS收集的现实数据,以了解处方模式和信息需求.
研究的目的:
- 描述医用大麻咨询的患者人口统计和临床指示.
- 确定从CMAS寻求的医疗保健专业人员信息的类型.
- 为医用大麻治疗提供临床指南的制定提供信息.
主要方法:
- 分析了从2021年1月到2022年6月的一组非识别患者特定调查.
- 数据包括使用医学监管活动词典 (MedDRA) 编码的患者诊断,说明和并发症.
- 使用R版本4.2.1.1进行统计分析.
主要成果:
- 大多数询问 (83.7%) 来自全科医生,男性和女性患者的比例相似.
- 常见的诊断包括骨关节炎,焦虑和慢性疼痛;经常报告的迹象是慢性疼痛,焦虑,背痛和失眠.
- 医疗从业者主要考虑处方大麻二醇 (CBD) 产品,通常是THC:CBD比例约为1:1或仅含CBD的配方.
结论:
- 这项研究强调了医疗从业人员关于医用大麻处方的关键信息需求.
- 这些发现强调了在这个治疗领域对临床决策支持的需求.
- 数据可以指导为医疗保健提供者创建有针对性的临床资源和教育材料.
相关概念视频
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
142
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
142
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Administration and Therapy Phases: Overview
409
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
409


